ivermectin oral / Generic mfg. 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 


«12...118119120121122123124125126127128129130
  • ||||||||||  ivermectin oral / Generic mfg.
    Enrollment open, Trial initiation date:  Ocular Changes After Ivermectin - (DOLF IVM/Oncho) (clinicaltrials.gov) -  Oct 3, 2018   
    P=N/A,  N=300, Enrolling by invitation, 
    Active, not recruiting --> Completed Not yet recruiting --> Enrolling by invitation | Initiation date: May 2018 --> Aug 2018
  • ||||||||||  albendazole / Generic mfg.
    Trial initiation date:  Efficacy and Safety of IVM/ALB Co-administration (clinicaltrials.gov) -  Aug 13, 2018   
    P2/3,  N=1960, Not yet recruiting, 
    Not yet recruiting --> Enrolling by invitation | Initiation date: May 2018 --> Aug 2018 Initiation date: Jun 2018 --> Sep 2018
  • ||||||||||  azithromycin / Generic mfg.
    Enrollment open:  IVERAZITH: Treatment of Pediculosis (Head Lice) in Senegal (clinicaltrials.gov) -  Aug 8, 2018   
    P=N/A,  N=450, Recruiting, 
    Initiation date: Jun 2018 --> Sep 2018 Not yet recruiting --> Recruiting
  • ||||||||||  ivermectin oral / Generic mfg.
    New P3 trial:  Treatment of Strongyloides Infection (clinicaltrials.gov) -  Jul 29, 2018   
    P3,  N=200, Recruiting, 
  • ||||||||||  ivermectin oral / Generic mfg.
    Enrollment closed, Enrollment change, Trial primary completion date:  STRONGTREAT: Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis (clinicaltrials.gov) -  May 25, 2017   
    P3,  N=312, Active, not recruiting, 
    Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | N=400 --> 312 | Trial primary completion date: Dec 2017 --> May 2018
  • ||||||||||  albendazole / Generic mfg.
    Enrollment open:  Twice Yearly Treatment for the Control of LF (clinicaltrials.gov) -  May 25, 2017   
    P4,  N=1440, Recruiting, 
    Recruiting --> Active, not recruiting | N=400 --> 312 | Trial primary completion date: Dec 2017 --> May 2018 Not yet recruiting --> Recruiting
  • ||||||||||  albendazole / Generic mfg.
    Trial initiation date:  Twice Yearly Treatment for the Control of LF (clinicaltrials.gov) -  Apr 17, 2017   
    P4,  N=1440, Not yet recruiting, 
    Not yet recruiting --> Recruiting Initiation date: Mar 2017 --> Jun 2017
  • ||||||||||  albendazole / Generic mfg.
    Enrollment closed, Trial initiation date, Trial primary completion date:  Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa (clinicaltrials.gov) -  Oct 12, 2016   
    P2,  N=182, Active, not recruiting, 
    Initiation date: Sep 2016 --> Mar 2017 | Trial primary completion date: Sep 2018 --> Mar 2019 Recruiting --> Active, not recruiting | Initiation date: Oct 2013 --> May 2014 | Trial primary completion date: Feb 2017 --> Dec 2017
  • ||||||||||  ivermectin oral / Generic mfg.
    Trial primary completion date:  STRONGTREAT: Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis (clinicaltrials.gov) -  Aug 8, 2016   
    P3,  N=400, Recruiting, 
    Recruiting --> Active, not recruiting | Initiation date: Oct 2013 --> May 2014 | Trial primary completion date: Feb 2017 --> Dec 2017 Trial primary completion date: Dec 2015 --> Aug 2016
  • ||||||||||  ivermectin oral / Generic mfg.
    Enrollment open, Trial initiation date, Trial primary completion date:  SCRATCH: Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults (clinicaltrials.gov) -  Jun 9, 2016   
    P3,  N=502, Recruiting, 
    Trial primary completion date: Dec 2015 --> Aug 2016 Not yet recruiting --> Recruiting | Initiation date: Sep 2015 --> Jan 2016 | Trial primary completion date: Apr 2017 --> Sep 2017
  • ||||||||||  ivermectin oral / Generic mfg.
    Trial primary completion date:  STRONGTREAT: Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis (clinicaltrials.gov) -  Dec 14, 2015   
    P3,  N=400, Recruiting, 
    Not yet recruiting --> Recruiting | Initiation date: Sep 2015 --> Jan 2016 | Trial primary completion date: Apr 2017 --> Sep 2017 Trial primary completion date: Mar 2015 --> Dec 2015
  • ||||||||||  ivermectin oral / Generic mfg.
    Enrollment open:  Efficacy and Safety of Ivermectin Against Dengue Infection (clinicaltrials.gov) -  Nov 2, 2015   
    P2/3,  N=360, Recruiting, 
    Trial primary completion date: Dec 2016 --> Apr 2017 Not yet recruiting --> Recruiting
  • ||||||||||  ivermectin oral / Generic mfg.
    Trial completion:  Development of Ivermectin for Alcohol Use Disorders (clinicaltrials.gov) -  Aug 20, 2015   
    P1/2,  N=11, Completed, 
    Not yet recruiting --> Recruiting Not yet recruiting --> Completed